Evidence map›Paper›PMID 26469320›Full record

SynthesisPain2015

Neuropathic pain phenotyping by international consensus (NeuroPPIC) for genetic studies: a NeuPSIG systematic review, Delphi survey, and expert panel recommendations.

Oliver van Hecke, Peter R Kamerman, Nadine Attal, Ralf Baron, Gyda Bjornsdottir, David L H Bennett, Michael I Bennett, Didier Bouhassira, Luda Diatchenko, Roy Freeman and 9 more

Erratum issuedAbstract readSystematic Review
In one paragraph

Synthesis in Pain, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 36 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Optimal clinical assessment strategies for chemotherapy-induced peripheral neuropathy (CIPN): a systematic review and Delphi survey.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2017
    Pooled it
  4. Article
  5. Phenotyping Chronic Pain and Neuropathic Pain in Population Studies.European journal of pain (London, England) · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

Oliver van HeckeDivision of Population Health Sciences, University of Dundee, Dundee, Scotland, United Kingdom Brain Function Research Group, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa INSERM U-987, Centre d'Evaluation et de Traitement de la Douleur, CHU Ambroise Paré, Assistance Publique Hôpitaux de Paris, Boulogne-Billancourt, France Université Versailles Saint-Quentin, Versailles, France Division of Neurological Pain Research and Therapy, Department of Neurology, Universitätsklinikum Schleswig-Holstein, Kiel, Germany deCODE Genetics/Amgen, Reykjavík, Iceland Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom Academic Unit of Palliative Care, Leeds Institute of Health Sciences, University of Leeds, Leeds, United Kingdom The Alan Edwards Centre for Research on Pain, McGill University, Montreal, Canada Department of Neurology, Beth Israel Deaconess Medical Centre, Harvard Medical School, Boston, USA Zentrum für Anästhesiologie, Intensivmedizin, Schmerztherapie und Palliativmedizin, Benedictus Krankenhaus, Tutzing, Germany Klinik für Anästhesiologie, Technische Universität München, München, Germany Department of Neurosurgery, Helsinki University Central Hospital, Helsinki, Finland Mutual Insurance Company Etera, Helsinki, Finland Department of Clinical Medicine, Danish Pain Research Center, Aarhus University, Aarhus, Denmark Department of Neurology, Aarhus University Hospital, Aarhus, Denmark Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University, School of Medicine, Baltimore, USA Pain Research, Department of Surgery and Cancer, Faculty of Medicine, Imperial College, Chelsea and Westminster Hospital campus, London, United Kingdom Pain Phenomics and Genomics Lab, University of Toronto Centre for the Study of Pain, University of Toronto, Toronto, Canada Department of Neurology, Technion Faculty of Medicine, Rambam Health Care Campus, Haifa, Israel (O. van Hecke is now with Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom).
Peter R Kamerman
Nadine Attal
Ralf Baron
Gyda Bjornsdottir
David L H Bennett
Michael I Bennett
Didier Bouhassira
Luda Diatchenko
Roy Freeman
Rainer Freynhagen
Maija Haanpää
Troels S Jensen
Srinivasa N Raja
Andrew S C Rice
Ze'ev Seltzer
Thorgeir E Thorgeirsson
David Yarnitsky
Blair H Smith

Funding

Genes for human chronic pain syndromes through whole genome sequencingR01DE022905 · NIDCR · DECODE GENETICS, EHF · PI STEFANSSON, KARI · 2012 to 2016
$2.6M
Medical Research Council MR/M02394X/1NIDCR NIH HHS R01 DE022905NIDCR NIH HHS R01DE022905Wellcome Trust 077074Wellcome Trust 095698Wellcome Trust 102645
6 · The paper itself

Abstract

For genetic research to contribute more fully to furthering our knowledge of neuropathic pain, we require an agreed, valid, and feasible approach to phenotyping, to allow collaboration and replication in samples of sufficient size. Results from genetic studies on neuropathic pain have been inconsistent and have met with replication difficulties, in part because of differences in phenotypes used for case ascertainment. Because there is no consensus on the nature of these phenotypes, nor on the methods of collecting them, this study aimed to provide guidelines on collecting and reporting phenotypes in cases and controls for genetic studies. Consensus was achieved through a staged approach: (1) systematic literature review to identify all neuropathic pain phenotypes used in previous genetic studies; (2) Delphi survey to identify the most useful neuropathic pain phenotypes and their validity and feasibility; and (3) meeting of experts to reach consensus on the optimal phenotype(s) to be collected from patients with neuropathic pain for genetic studies. A basic "entry level" set of phenotypes was identified for any genetic study of neuropathic pain. This set identifies cases of "possible" neuropathic pain, and controls, and includes: (1) a validated symptom-based questionnaire to determine whether any pain is likely to be neuropathic; (2) body chart or checklist to identify whether the area of pain distribution is neuroanatomically logical; and (3) details of pain history (intensity, duration, any formal diagnosis). This NeuroPPIC "entry level" set of phenotypes can be expanded by more extensive and specific measures, as determined by scientific requirements and resource availability.

Indexed as

Delphi TechniqueInternational CooperationNeuralgiaConsensus Statements as TopicDatabases, BibliographicHumansPain MeasurementPhenotype

Identifiers

PMID26469320
PMCPMC4747983

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.